Clinical Trials Database


Auto Draft (December 17, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 15, 2015)
Auto Draft (October 5, 2015)
Auto Draft (October 5, 2015)
Auto Draft (October 5, 2015)
Auto Draft (October 5, 2015)
Auto Draft (October 5, 2015)
Auto Draft (October 5, 2015)
Open-label, uncontrolled Phase II trial of intravenouse P13K inhibitor BAY 80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas (August 3, 2015)

Objective The objective of study is to evaluate the efficacy and safety of copanlisib in patients with indolent B-cell NHL, relapsed or refractory to widely used approved therapies in standard practice. Overview Eligibility... Continue Reading

An observational study for patients with newly diagnosed ERH 2+ metastatic breast cancer (December 3, 2014)

Objective Overview Eligibility Requirements Contact Centers Jackson Oncology Associates, PLLC1227 North State Street, Suite 101JacksonMississippi39202Teresa Davis, RN, OCNteresadavis@mbhs.org601-355-2485  Read More →

A Phase 2 Study of LY2523355 in Patients with Extensive-Stage Small Cell Lung Cancer (March 26, 2012)

Objective Overview Eligibility Requirements Contact Centers University of New Mexico1201 Camino de Salud NE, MSC07-4025AlbuquerqueNew Mexico87131Valerie Parks, RNClinicalTrialInfo@salud.unm.edu505-925-0390  Read More →

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS